Jin Han

3.2k total citations · 1 hit paper
78 papers, 2.1k citations indexed

About

Jin Han is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Jin Han has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 29 papers in Hematology and 11 papers in Molecular Biology. Recurrent topics in Jin Han's work include Hemoglobinopathies and Related Disorders (35 papers), Iron Metabolism and Disorders (21 papers) and Blood groups and transfusion (9 papers). Jin Han is often cited by papers focused on Hemoglobinopathies and Related Disorders (35 papers), Iron Metabolism and Disorders (21 papers) and Blood groups and transfusion (9 papers). Jin Han collaborates with scholars based in United States, China and South Korea. Jin Han's co-authors include Albert Bendelac, Michael G. Constantinides, Olivier Lantz, Damien Picard, Emmanuel Martin, Bofeng Li, Adam K. Savage, Tse‐Hua Tan, Victor R. Gordeuk and Santosh L. Saraf and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jin Han

69 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage

2008 563 citations Jin Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jin Han United States	22	873	599	322	318	301	78	2.1k
Marc Vaudel Norway	29	186 0.2×	1.7k 2.8×	142 0.4×	89 0.3×	490 1.6×	77	2.7k
Masaki Murata Japan	34	369 0.4×	1.4k 2.4×	532 1.7×	85 0.3×	43 0.1×	123	3.4k
Laurence Gamé United Kingdom	24	270 0.3×	1.4k 2.3×	65 0.2×	188 0.6×	136 0.5×	57	2.4k
Peng Wei United States	30	243 0.3×	1.5k 2.6×	257 0.8×	182 0.6×	202 0.7×	178	3.2k
Mikael Benson Sweden	29	418 0.5×	1.2k 2.0×	136 0.4×	33 0.1×	44 0.1×	80	2.4k
Richard McIndoe United States	23	696 0.8×	1.0k 1.7×	256 0.8×	52 0.2×	65 0.2×	63	2.8k
Hongyan Wu China	25	371 0.4×	703 1.2×	475 1.5×	81 0.3×	31 0.1×	154	2.1k
Younghee Lee United States	23	518 0.6×	1.0k 1.7×	629 2.0×	142 0.4×	329 1.1×	93	2.4k
Xiaoli Cui China	20	100 0.1×	541 0.9×	309 1.0×	82 0.3×	93 0.3×	89	1.6k

Countries citing papers authored by Jin Han

Since Specialization

Citations

This map shows the geographic impact of Jin Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Han more than expected).

Fields of papers citing papers by Jin Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Han. The network helps show where Jin Han may publish in the future.

Co-authorship network of co-authors of Jin Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Han. A scholar is included among the top collaborators of Jin Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Han. Jin Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fu, Liwen, Jin Han, Lü Rong, et al.. (2025). Protective effects of medicinal plant-derived metabolites in cardiovascular disease targeting exosomal pathways. Frontiers in Pharmacology. 16. 1681625–1681625.

Yao, Yunfeng, Qi Wen, Fubin Liu, et al.. (2024). Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response. Virology Journal. 21(1). 329–329. 1 indexed citations

Park, Joshua J, et al.. (2024). Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention. Pharmacogenomics. 25(7). 293–298.

Han, Jin, et al.. (2023). Iron Overload and Treatment Outcome in an Adult Sickle Cell Disease Cohort. Blood. 142(Supplement 1). 5331–5331.

Kim, Kibum, Julio D. Duarte, William Galanter, et al.. (2023). Pharmacist-Guided Pharmacogenetic Service Lowered Warfarin-Related Hospitalizations. Pharmacogenomics. 24(6). 303–314. 2 indexed citations

Han, Jin, Santosh L. Saraf, & Victor R. Gordeuk. (2023). Vaccination in sickle cell disease: Immunocompromised or immunocompetent?. British Journal of Haematology. 202(5). 916–918. 2 indexed citations

Han, Jin, Andrew Srisuwananukorn, Binal N. Shah, et al.. (2021). Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease. SHILAP Revista de lepidopterología. 2(3). 483–484. 5 indexed citations

Zhou, Jifang, Gregory S. Calip, Edith A. Nutescu, et al.. (2021). Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12‐year single health system‐based cohort analysis. SHILAP Revista de lepidopterología. 2(1). 94–98. 2 indexed citations

Zhang, Xu, Binal N. Shah, Roberto F. Machado, et al.. (2021). Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study. British Journal of Haematology. 194(4). 767–778. 8 indexed citations

10.

Zhou, Jifang, Karen Sweiss, Edith A. Nutescu, et al.. (2021). Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncology Practice. 17(3). e294–e312. 9 indexed citations

11.

Minniti, Caterina P., Ahmar U. Zaidi, Mehdi Nouraie, et al.. (2021). Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection. Blood Advances. 5(1). 207–215. 51 indexed citations

12.

Han, Jin, Santosh L. Saraf, & Victor R. Gordeuk. (2020). Systematic Review of Voxelotor: A First‐in‐Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(6). 525–534. 19 indexed citations

13.

Han, Jin, Santosh L. Saraf, & Victor R. Gordeuk. (2020). Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso‐occlusive Pain Crises in Patients with Sickle Cell Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(6). 535–543. 23 indexed citations

14.

Han, Jin, Christopher Holden, Robert E. Molokie, et al.. (2020). Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. British Journal of Haematology. 191(3). e70–e72. 4 indexed citations

15.

Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2019). Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six‐year population‐based cohort analysis. British Journal of Haematology. 185(1). 116–127. 12 indexed citations

16.

Zhou, Jifang, Jin Han, Edith A. Nutescu, et al.. (2018). Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6‐year population‐based cohort study. British Journal of Haematology. 182(2). 259–270. 13 indexed citations

17.

Han, Jin, Xu Zhang, Santosh L. Saraf, et al.. (2018). Risk factors for vitamin D deficiency in sickle cell disease. British Journal of Haematology. 181(6). 828–835. 18 indexed citations

18.

Han, Jin, Jifang Zhou, Santosh L. Saraf, Victor R. Gordeuk, & Gregory S. Calip. (2017). Characterization of opioid use in sickle cell disease. Pharmacoepidemiology and Drug Safety. 27(5). 479–486. 41 indexed citations

19.

Zhou, Jifang, Gregory S. Calip, Jin Han, & Edith A. Nutescu. (2017). Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study. Blood. 130. 2139–2139. 1 indexed citations

20.

Yan, Qiang, Jin Han, Yingjiu Li, & Robert H. Deng. (2012). On Limitations of Designing Usable Leakage-Resilient Password Systems: Attacks, Principles and Usability. Institutional Knowledge (InK) - Institutional Knowledge at Singapore Management University (Singapore Management University). 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact